{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:59:02Z","timestamp":1759496342941,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T00:00:00Z","timestamp":1678320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.aprim.2023.102606","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T06:01:26Z","timestamp":1678860086000},"page":"102606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of the effectiveness of four SARS-COV-2 v accines in Nuevo Leon, Mexico: A test-negative control study"],"prefix":"10.1016","volume":"55","author":[{"given":"Ana Mar\u00eda","family":"Salinas-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar P.","family":"Rodr\u00edguez-Vidales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Garza-Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia A.","family":"Robles-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Montes de","family":"Oca-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma Rosa","family":"Marroqu\u00edn-Escamilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2023.102606_bib0095","unstructured":"WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int [accessed 26.10.21]."},{"key":"10.1016\/j.aprim.2023.102606_bib0100","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.abe6959","article-title":"Model-informed COVID-19 vaccine prioritization strategies by age and serostatus","volume":"371","author":"Bubar","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.aprim.2023.102606_bib0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.aprim.2023.102606_bib0110","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1080\/21645515.2020.1766939","article-title":"Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries","volume":"16","author":"Anjum","year":"2020","journal-title":"Hum Vacc Immunotherap"},{"year":"2021","series-title":"A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease","author":"Higdon","key":"10.1016\/j.aprim.2023.102606_bib0115"},{"key":"10.1016\/j.aprim.2023.102606_bib0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2023.102606_bib0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/vaccines8040668","article-title":"Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses","volume":"8","author":"Makhoul","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.aprim.2023.102606_bib0130","doi-asserted-by":"crossref","first-page":"12051","DOI":"10.1038\/s41598-021-91514-7","article-title":"A model and predictions for COVID-19 considering population behavior and vaccination","volume":"11","author":"Usherwood","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.aprim.2023.102606_bib0135","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","author":"Fiolet","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.aprim.2023.102606_bib0140","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMe2113151","article-title":"Covid-19 vaccine effectiveness and the test-negative design","volume":"385","author":"Dean","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2023.102606_bib0145","first-page":"ciab640","article-title":"Prevention of COVID-19 by mRNA-based vaccines within the general population of California","author":"Andrejko","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aprim.2023.102606_bib0150","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2023.102606_bib0155","first-page":"100154","article-title":"Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: a population-based study","volume":"6","author":"Cerqueira-Silva","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.aprim.2023.102606_bib0160","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(21)01358-1","article-title":"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness","volume":"397","author":"Sheikh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2023.102606_bib0165","first-page":"1","article-title":"Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: a test-negative case\u2013control study","author":"Hitchings","year":"2021","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.aprim.2023.102606_bib0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2023.102606_bib0175","doi-asserted-by":"crossref","first-page":"2096970","DOI":"10.1080\/21645515.2022.2096970","article-title":"CoronaVac: a review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2","volume":"18","author":"Jin","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.aprim.2023.102606_bib0180","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMoa2110362","article-title":"Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings","volume":"385","author":"Thompson","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656723000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656723000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:03:29Z","timestamp":1759323809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656723000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0212656723000392"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2023.102606","relation":{},"ISSN":["0212-6567"],"issn-type":[{"type":"print","value":"0212-6567"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the effectiveness of four SARS-COV-2 v accines in Nuevo Leon, Mexico: A test-negative control study","name":"articletitle","label":"Article Title"},{"value":"Atenci\u00f3n Primaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aprim.2023.102606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102606"}}